Search for: "GENENTECH, INC."
Results 301 - 320
of 469
Sorted by Relevance
|
Sort by Date
18 Jan 2014, 10:57 am
BAE Systems: 8,576,108 (active expendable decoy to fool enemy missiles); Children's Medical Center: 8,597,910 (DNA encoding Von Willebrand Factor Proteins); Colgate-Palmolive: 8,535,730 (tarter control toothpaste); Genentech, Inc.: 8,357,513; 8,399,250; 8,557,768 (genes and methods relating to the human mpl ligand polypeptide); Institut Pasteur: 8,507,196 (A kit for determining the absence of HIV-1 RNA in a biological sample); Personalized Media Communications: 8,395,707;… [read post]
6 Aug 2018, 1:40 pm
The responsible drug company is Genentech, Inc. [read post]
6 Dec 2010, 7:43 pm
Genentech, Inc., 927 F.2d 1565, 1580 (Fed. [read post]
17 Sep 2018, 10:27 am
Genentech, Inc., 549U.S. 118, 127 (2007)).Such a controversy exists here because DuPont currentlyoperates a plant capable of infringing the ’921patent. [read post]
13 Jul 2015, 3:51 am
| Plant variety in Case C‑242/14 | US Supreme Court on spiderman patent | Hospira v Genentech saga | Are EU policy-makers fighting the right copyright battles? [read post]
18 Oct 2006, 5:26 pm
ADB Utility Contractors, Inc. (14-CA-27386, et al.; 348 NLRB No. 53) St. [read post]
25 May 2015, 5:15 pm
Board member Steven Juelsgaard, former executive vice president of Genentech, raised questions about what might happen if the board rejected the NeoStem application, given that it has only $19 million on hand at last report. [read post]
5 Dec 2014, 10:49 am
Recently, Nyarady’s successful representation of industry leader Edwards Lifesciences against Medtronic, Inc. resulted a 1 billion-dollar settlement. [read post]
14 Oct 2017, 6:49 pm
’ In the 1997 case of Genentech, Inc. v Chiron Corp. 112 F.3d 495 the CAFC expressly stated that: ‘”Comprising” is a term of art used in claim language which means that the named elements are essential, but other elements may be added and still form a construct within the scope of the claim. [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
1 Mar 2011, 8:38 pm
Roche Molecular Systems, Inc. [read post]
21 Apr 2009, 2:20 pm
., biotech [Biogen Idec Inc. [read post]
11 Oct 2011, 12:43 pm
Genentech, Inc., 549 U.S. 118, 132 n. 11 (2007) and its progeny. [read post]
27 Jul 2009, 6:40 am
Genentech, Inc., the question of "evergreening" patents was presented as both abusing and compromising the integrity of the patent system. n36 Evergreening allows inventors to file endless continuation applications, issuing patent after patent based upon on a single original patent filing.The process of continuing and patenting and continuing and patenting can continue until the 20-year patent term is finally exhausted. [read post]
8 Sep 2016, 11:29 am
Genentech, Inc., 549 U.S. 118, 127 (2007) In MedImmune, the Court explained the test as “whether the facts alleged, under all the circumstances, show that there is a substantial controversy, between parties having adverse legal interests, of sufficient immediacy and reality to warrant the issuance of a declaratory judgment. [read post]
Written Description: Description Must do more than Allow PHOSITA to “Envision” the Claimed Invention
7 Sep 2010, 9:30 am
Gen-Probe Inc., 323 F.3d 956, 968 (Fed. [read post]
21 Jul 2008, 11:24 am
Genentech, Inc., 127 S. [read post]
24 Apr 2014, 7:40 am
Cir. 2009); In re Genentech Inc., 566 F.3d 1338 (Fed. [read post]
8 Dec 2009, 12:33 pm
Genentech, Inc., wittingly or not, lowered the bar for declaratory judgment actions. [read post]
5 Jan 2011, 2:24 pm
On appeal, the Federal Circuit granted Microsoft's request for a writ, likening this case to In re Genentech, Inc., 566 F.3d 1338 (Fed. [read post]
